StackTerminal.Health

BETA

Modafinil

Modafinil is a wakefulness-promoting agent approved for narcolepsy & shift work disorder, & is widely used off-label as a cognitive enhancer with evidence for improving attention, working memory, & decision-making.

focuscognitiveenergywakefulness
Evidence last reviewed: 05 Apr 2026
Biomarkers studied
Outcomes directly measured across the evidence records below
Cognitive
Cognitive FunctionFocus / Attention
Evidence
3 records
Cognitive enhancement
Adults with treatment-resistant depressionSystematic review
PUBMEDModerate

Modafinil showed significant efficacy in cognitive enhancement compared to placebo.

Dose: 200 mg
Wakefulness
Adults with narcolepsySystematic review
PUBMEDHigh

Modafinil is effective in promoting wakefulness in patients with narcolepsy.

Dose: 200 mg
Treatment of stimulant use disorder
Adults with amphetamine-type stimulant use disorderSystematic review and meta-analysis
PUBMEDModerate

Modafinil showed efficacy in the treatment of amphetamine-type stimulant use disorder.

Dose: 200 mg
Forms
Tablet
Commonly available in 100 mg and 200 mg doses.

Stacks containing Modafinil

Public community stacks that include this ingredient.

Explore all stacks →
cognitiveenergyfocus

Modafinil & methylene blue are combined to enhance cognitive function & energy levels. Modafinil is a wakefulness-promoting agent that improves focus, while methylene blue supports mitochondrial function & cognitive performance.

Modafinil
100mg
Methylene Blue
2mg
New
View